Previous 10 | Next 10 |
PR Newswire news releases related Pr Newswire news releases and Pr Newswire press releases from 06/09/23 06:41:00 on US and Canada Markets.
Ping An Ranks 16th in Forbes' Global 2000, 7th among Global Financial Enterprises PR Newswire HONG KONG and SHANGHAI , June 9, 2023 /PRNewswire/ -- Ping An Insurance (Group) Company of China , Ltd. (hereafter " Ping An ", the "Company" or the "Group",...
AZZ Inc. Appoints Tiffany Moseley as Chief Accounting Officer PR Newswire FORT WORTH, Texas , June 9, 2023 /PRNewswire/ -- AZZ Inc. (NYSE: AZZ) , the leading independent provider of hot-dip galvanizing and coil coating solutions in North America , today a...
Consumers Energy Foundation Awards $50,000 for Winners of the Put Your Town on the Map Competition PR Newswire Winning communities of Fennville , Reed City , and Harbor Beach will use awards to complete community projects JACKSON, Mich. , June 9, ...
WATERDROP ANNOUNCES THE PROPOSED ACQUISITION OF CUNZHEN QIUSHI PR Newswire BEIJING , June 9, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a p...
Tuniu Announces Unaudited First Quarter 2023 Financial Results PR Newswire NANJING , China , June 9, 2023 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China , today announced its u...
Yiren Digital Reports First Quarter 2023 Financial Results PR Newswire BEIJING , June 9, 2023 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading digital personal financial management platform in China , today announce...
New biomarker data from BEXMAB study at EHA2023 PR Newswire Faron Pharmaceuticals Oy ("Faron" or "the Company") Faron Announces New Biomarker Data from Phase I/II BEXMAB Study at EHA2023 Hybrid Congress Bexmarilimab mode of action in AML/MDS supported wit...
AbbVie's VENCLYXTO®/VENCLEXTA® (venetoclax) Continues to Show Sustained Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) Patients PR Newswire Data from two studies continue to show the long-term efficacy and safety of fixed-duration venetoclax ...
Hengtong Optic-Electric Releases 2022 ESG Report at the PT Expo PR Newswire BEIJING , June 9, 2023 /PRNewswire/ -- During the 31st China International Information and Communications Exhibition (PT Expo) on June 5th , Hengtong Optic-Electric held the Hengtong ...
Gilteritinib as Maintenance Therapy Demonstrated Benefit in Subgroups of FLT3-ITD Acute Myeloid Leukemia Patients PR Newswire Data from Phase 3 MORPHO trial selected for press briefing and to be presented as oral session during the 2023 European Hematology Association (EHA) Hy...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
21.21%Change Percent:
Lightbridge Corporation Company Name:
LTBR Stock Symbol:
NASDAQ Market:
ltbridge.com Website: